Biostone Pharmaceuticals Private Limited
About Biostone Pharmaceuticals Private Limited
Data last updated:
Biostone Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC270215. Its GSTIN is 07AAFCB9949P1ZR (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prashant Kumar and Aakash Kumar.
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L – 347 Extn Mohan Garden Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.71 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹32,914 (net margin 1.3%) and EBITDA of ₹35,026 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Biostone Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressL – 347 Extn Mohan Garden Uttam Nagar, Delhi, India – 110059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biostone Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biostone Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biostone Pharmaceuticals Private Limited, buy the company report.
Financials of Biostone Pharmaceuticals Private Limited
FY 2025 filings availableBiostone Pharmaceuticals Private Limited reported revenue of ₹24.71 Lakh (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 16% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35,026 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32,914 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biostone Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biostone Pharmaceuticals Private Limited
Biostone Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Kumar | Director | 11 Aug 2014 | 12 Years 2 Months | Current |
| Aakash Kumar | Director | 11 Aug 2014 | 12 Years 2 Months | Current |
| Sangeeta | Director | 02 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Biostone Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raush Pharmaceuticals Private Limited | ₹24.79 Lakh (FY 2025) | -11.0% | Ambala Cantt, Haryana, India | |||
| Innovexa Healthcare Private Limited | ₹24.78 Lakh (FY 2024) | 35.0% | Jabalpur, Madhya Pradesh, India | |||
| Biostone Pharmaceuticals Private Limitedthis company | ₹24.71 Lakh (FY 2025) | ₹32,914 | 1.3% | 16.0% | Delhi, India | |
| Benz Lifecare Private Limited | ₹24.68 Lakh (FY 2024) | -19.0% | Delhi, India | |||
| Reitrue Pharmaceutical Private Limited | ₹24.61 Lakh (FY 2019) | 347.0% | Thane, Maharashtra, India |
To see the full peer comparison of Biostone Pharmaceuticals Private Limited, buy the company report.
Auditor
Biostone Pharmaceuticals Private Limited is audited by G G P & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G G P & ASSOCIATES | FY 2019 | 029770N |
Shareholding
The shareholding of Biostone Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Biostone Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biostone Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biostone Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biostone Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCB9949P1ZR | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biostone Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biostone Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Vinit Kumar ceased to be Director on 16 Aug 2016.
Frequently asked questions
Biostone Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2014 (12+ years old) and is registered under CIN U24100DL2014PTC270215.
Biostone Pharmaceuticals has 3 current directors:
- Prashant Kumar - Director
- Aakash Kumar - Director
- Sangeeta - Director
The latest financial statements of Biostone Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biostone Pharmaceuticals is 07AAFCB9949P1ZR, registered in Delhi.
The CIN (Corporate Identification Number) of Biostone Pharmaceuticals is U24100DL2014PTC270215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biostone Pharmaceuticals was incorporated on 11 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biostone Pharmaceuticals by revenue are Raush Pharmaceuticals Private Limited, Innovexa Healthcare Private Limited, Benz Lifecare Private Limited, Reitrue Pharmaceutical Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Vinit Kumar ceased to be Director on 16 Aug 2016. Sangeeta was appointed as Director on 02 Nov 2014. Aakash Kumar was appointed as Director on 11 Aug 2014. Biostone Pharmaceuticals has 4 board changes on record in total.
The registered office of Biostone Pharmaceuticals is at L – 347 Extn Mohan Garden Uttam Nagar, Delhi, India – 110059.
Biostone Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Biostone Pharmaceuticals is compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
